[ad_1]
The announcement of the world's first cancer drug, Love at first sight on social networking sites, was announced and everyone took the initiative to share this news and comment on it, making it a real pleasure. good news for all people with the disease. What are the medical details of this topic?
After the Food and Drug Administration (FDA) announced the world's first drug that can treat cancer from its original source in adults and young people, hope has returned to many injured people in the world. Lebanon and around the world, where approval has sparked a "fuss" among everyone, especially the Social Networking Sites. As part of the details of this drug and if it can be obtained in Lebanon, Al-Gomhouria had a special conversation with a graduate of an American hospital, former professor at the University of Florida and current head of the department of Oncology Clemenceau Medical Center, Professor Nicolas Zouin, who said: That this topic has attracted the attention of all those affected by the disease and those who are not, due to the ratification of the leave and the establishment of this drug, a very important and unique step in the history of medicine, oncology and the FDA, to the extent that this drug does not treat a specific type of cancer, but treats the base of the cancerous tumor genes regardless of the location of its origin in the human body. To obtain FDA approval, research must first be done on cells in the laboratory and then on animals. Once the effectiveness of the drug is determined in parallel with the acceptable side effects, the details of the tests are subject to the approval of the administration, which then decides to accept or reject it .
Treat these types of cancer!
In the past, cancer was treated according to the source of the cancerous tumor, but currently the treatment will be directed to any part of the body because the drug treats the original gene that caused the tumor to develop. . He explains d. "This drug is found in the brain, nerves and sensory cells, causing cancerous mutations, including glandular cancer and some cancers in children.This drug can be used by going to the laboratory to examine the gene after n & # 39; Any type of cancer and if the cause of the infection is treated with "Vitrakvi" (name of the drug) .This is not the first drug to target a particular gene, but it is not the only medicine to target a particular gene is the first time that the type of cancer has not been determined.It is as if we said that the drug does not care about the name of the cancer, its type or the place It is only important that mutations infect the "NTRK" gene.
Does this eliminate other treatments?
The drug was actually tested on Anna Plaza and her daughter Rihanna last year, after a cancerous tumor for Anna. Her daughter Rihanna Burm was born with cancer on her arm. Vitrakvi was given daily to the newborn daughter and scientists were surprised to find that the tumor began to contract after just three days: after a few months, the tumor was completely eradicated and They did not have to cut the little arm of the baby. But does this drug eliminate other cancer treatments? Answer d. "We do not know yet whether they will siphon chemical, radiological or surgical treatments, and even this drug is still new and limited, especially when it's used in a lot of people. to know how effective it is.And what are its side effects.In the future, cancer cells may also be resistant to this drug.Also, the drug comes in two forms, the first in the form of tablets or capsules and the other form of medicine, especially for children, and takes itself during an annual recovery period.
Lebanon and the cost
Despite all the hopes that this drug offers to people who apply this treatment, the main problem of science as a whole is the prohibitive cost of treatment. What about Lebanon? Dr. "It costs $ 400,000 to treat this medicine for a year, or to be more specific, its cost is $ 393,000," he said. "These are not the tests that a patient should undergo, nor the hospital and other costs related to cancer patients, so it is very difficult for all those infected to receive such treatment. oncology concerns the whole world: the drug exists but the health coverage is absent.To Lebanon, this drug is approved and available on the market, nothing prevents its arrival in Lebanon, in case of agreement with the company of this drug. "" As specialists, we can say that all cancers begin with genetic mutations to cause disease later, and today we are in a new way of thinking. We will identify and target the source. In the future, we will of course see other drugs targeting these mutations, and thereafter, the high price of drugs and treatments for the patient is high. Knowing that the numbers we see today have not been seen before, we would have heard about expensive drugs, but not so much. "
Genie Jabbour – Republic
Source: Republic
Source link